Summit Research Network

Summary

Summit Research Network is a medical facility located in Portland, Oregon. This center is recognized for care of Alzheimer's Disease, Major Depressive Disorder, Depression, Migraine, Vestibular Migraine and other specialties. Summit Research Network is involved with conducting 136 clinical trials across 82 conditions. There are 2 research doctors associated with this hospital, such as Scott Losk and James H. Bergthold.

Top PIs

Clinical Trials running at Summit Research Network

Alzheimer's Disease

Breast Cancer

Cognitive Impairment

Breast cancer

Dementia

Screening

for Alzheimer's Disease Studies

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Recruiting

2 awards

Phase 3

Trontinemab

for Alzheimer's Disease

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

Recruiting

1 award

Phase 3

1 criteria

MK-1167

for Alzheimer's Disease

Researchers want to learn if giving MK-1167 (the study medicine) along with acetylcholinesterase inhibitor (AChEI) therapy can improve symptoms of Alzheimer's disease dementia (AD dementia), such as memory and mental activity. AD dementia is the most common type of dementia. AChEI therapy is the standard treatment for AD dementia. The goals of this study are to learn: * If at least one dose level (amount) of MK-1167 works to improve a person's memory and thinking compared to a placebo * About the safety of MK-1167 and if people tolerate it

Recruiting

0 awards

Phase 2

2 criteria